Literature DB >> 9034007

Genotypic association between dopamine transporter gene polymorphisms and schizophrenia.

A M Persico1, F Macciardi.   

Abstract

Dopamine transporter (DAT) gene variants do not appear to provide widespread contributions to the etiology of schizophrenia spectrum disorders, according to linkage studies [Persico et al., 1995: Am J Psychiatry 152:134-136]. They may, however, produce modifying effects, more readily detectable in specific subpopulations of schizophrenics through associations analyses. We therefore compared polymorphic DAT gene variable number tandem repeat (VNTR) distributions in 84 controls and 147 patients, divided according to DSM-IIIR schizophrenia type criteria. No evidence of allelic association between DAT alleles and schizophrenia or any specific schizophrenia subtype was found. Interestingly, the DAT genotype distribution among schizophrenic patients did display a statistically significant departure from the genotype distribution found in controls. Such discrepancies may represent stigmata of assortative mating or may suggest a "modifying" contribution of homozygote DAT genotypes to pathogenetic processes underlying schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9034007     DOI: 10.1002/(sici)1096-8628(19970221)74:1<53::aid-ajmg12>3.0.co;2-q

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  7 in total

1.  A Meta-analysis of the Association Between SLC6A3 Gene Polymorphisms and Schizophrenia.

Authors:  Feng-Ling Xu; Mei Ding; Xue Wu; Yong-Ping Liu; Xi Xia; Jun Yao; Bao-Jie Wang
Journal:  J Mol Neurosci       Date:  2019-08-22       Impact factor: 3.444

Review 2.  Molecular genetics of schizophrenia: past, present and future.

Authors:  Suman Prasad; Prachi Semwal; Smita Deshpande; Triptish Bhatia; V L Nimgaonkar; B K Thelma
Journal:  J Biosci       Date:  2002-02       Impact factor: 1.826

3.  MDMA "ecstasy" alters hyperactive and perseverative behaviors in dopamine transporter knockout mice.

Authors:  Susan B Powell; Virginia D Lehmann-Masten; Martin P Paulus; Raul R Gainetdinov; Marc G Caron; Mark A Geyer
Journal:  Psychopharmacology (Berl)       Date:  2004-01-28       Impact factor: 4.530

4.  Increased Nigral SLC6A3 Activity in Schizophrenia Patients: Findings From the Toronto-McLean Cohorts.

Authors:  James L Kennedy; Nian Xiong; Jinlong Yu; Clement C Zai; Jennie G Pouget; Jie Li; Kefu Liu; Hong Qing; Tao Wang; Eden Martin; Deborah L Levy; Zhicheng Lin
Journal:  Schizophr Bull       Date:  2015-12-26       Impact factor: 9.306

5.  Decreased vesicular monoamine transporter 2 (VMAT2) and dopamine transporter (DAT) function in knockout mice affects aging of dopaminergic systems.

Authors:  F S Hall; K Itokawa; A Schmitt; R Moessner; I Sora; K P Lesch; G R Uhl
Journal:  Neuropharmacology       Date:  2013-08-24       Impact factor: 5.250

6.  Polymorphisms in dopaminergic system genes; association with criminal behavior and self-reported aggression in violent prison inmates from Pakistan.

Authors:  Muhammad Imran Qadeer; Ali Amar; J John Mann; Shahida Hasnain
Journal:  PLoS One       Date:  2017-06-05       Impact factor: 3.240

7.  Polymorphisms in Dopaminergic Genes in Schizophrenia and Their Implications in Motor Deficits and Antipsychotic Treatment.

Authors:  Jiaen Ye; Feng Ji; Deguo Jiang; Xiaodong Lin; Guangdong Chen; Wei Zhang; Peiwei Shan; Li Zhang; Chuanjun Zhuo
Journal:  Front Neurosci       Date:  2019-04-17       Impact factor: 4.677

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.